DrugInfoSys

Inosine Pranobex

Drug #1728

Inosine Pranobex is an antiviral agent which is used in the treatment of herpes simplex infections of skin and mucous membranes. Inosine Pranobex is used as an adjunct in the treatment of genital warts.

Primary Characteristics

Molecular Weight: 1115.2 · Non-proprietary name: Inosine Pranobex.

Molecular structure of Inosine Pranobex

Pharmacokinetics

Absorption: Inosine Pranobex has an pre-systemic (first-pass) metabolism accounts for 45.5% (±4.5%).

Advertisement

Indications

Contraindications

None recorded.

Dosage

Inosine Pranobex's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
1 g1 gEvery 8hPOFor 7 to 14 days for mucocutaneous herpes simplex.
1 g1 gEvery 8hPOFor 14 to 28 days as an an adjunct to standard topical treatment for genital warts.
75 mg/kg75 mg/kgEvery 4hPOIn divided doses for subacute scherosing panencephalitis.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

The signs and symptoms that are produced after acute overdosage of Inosine Pranobex are Diarrhea, Drowsiness, Constipation, Drowsiness.

Inosine Pranobex is known to cause more or less tolerable side effects which are usually transient. These include athralgia, Fatigue, Headache, Itching, Joint pain, Nausea and vomiting, Skin rashes, Tiredness , Vertigo.

Warnings / Precautions

Inosine Pranobex should be avoided in patients with renal impairment; history of gout or hyperuricaemia.

Available Brands

None recorded.

Drug Classification

  1. 1.6.5.1Herpes and cytomegalovirus infection